-
BeiGene released the latest data at the 2022 European Conference on Oncology, including the results of an oral report on the study of terelizumab for first-line unresectable hepatocellular carcinoma
Time of Update: 2022-09-21
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Zhang Feng's new paper: CRISPR activation screening to discover key proteins of cancer immunotherapy resistance
Time of Update: 2022-04-23
The study found that BCL-2 and B3GNT2 are key drivers of cancer cell resistance to cytotoxic T cells through CRISPRa Screen, and inhibition of these two proteins can enhance the sensitivity of tumor tissue to immunotherapyThis result suggests that a CRISPR-activated screening system can help to elucidate resistance pathways and identify potential targets for cancer immunotherapy .
-
Professor Chen Xiaobing, an expert in oncology science, "Facing Cancer: Don't Panic or Follow Blindly" won the 2020 National Excellent Science Works Award from the Ministry of Science and Technology
Time of Update: 2021-12-24
In addition, this general undergraduate book won the 2021 Henan Province Excellent Popular Science Works (Books), and also won the "Most Popular Award" in the 2020 Healthy China ● Cancer Prevention Action Health Popular Science Competition .
-
FDA granted fast track qualification for the new immunotherapy nemvaleukin+Keytruda program
Time of Update: 2021-12-04
Alkermes recently announced that the US Food and Drug Administration (FDA) has granted nemvaleukin alfa (nemvaleukin) fast track designation (FTD), combined with Merck’s anti-PD-1 therapy Keytruda (generic name: pembrolizumab, pembrolizumab) Anti), used to treat platinum-resistant ovarian cancer .
-
CD73 monoclonal antibody
Time of Update: 2021-11-16
After this clinical approval, Jacos Pharmaceuticals will start a phase 1/2a clinical trial for patients with solid tumors in the United States .
-
[Science Sub-Journal] A cheap oral drug-arginine, can enhance the effect of cancer radiotherapy
Time of Update: 2021-11-14
Roffo Cancer Institute showed that treatment with arginine (an amino acid building block of protein) can enhance patients with cancer brain metastases The effectiveness of radiotherapy .
-
ANN NEUROL: Cancer patients have higher blood coagulation markers and are susceptible to ischemic stroke
Time of Update: 2021-11-12
The study found that compared with the control group, patients with active cancer and acute ischemic stroke had higher coagulation, platelet and endothelial cell activation markers, and more circulating microemboli .
-
Gastric Cancer: Triglyceride-glucose index can predict the occurrence of gastric cancer
Time of Update: 2021-08-27
Therefore, this project aims to study the relationship between the triglyceride-glucose (TyG) index and the occurrence of gastric cancer, including precancerous lesions such as dysplasia, atrophic gastritis and intestinal metaplasia .
-
Merck's oncology product lineup data presented on ASCO21 highlights major advances in cancer treatment
Time of Update: 2021-06-10
BAVENCIO 's approved indications In the United States, BAVENCIO is suitable for the maintenance treatment of locally advanced or metastatic urothelial carcinoma (UC) patients who have not progressed after first-line platinum-containing chemotherapy .
-
Sci. Adv.|Xu Liang/Chen Ye/Huang Yulun collaborated to reveal the active chromatin map of glioblastoma
Time of Update: 2021-05-22
In addition, by analyzing cancer-specific enhancer signals, the study discovered and identified a series of transcription factors, long non-coding RNAs and drug targets (such as MNK2 and BRD4, etc.
-
Regenerant Bioanti-TIGIT Monoantigen JS006 Injection was approved for clinical trials
Time of Update: 2021-01-29
On January 27, Junshi Bio announced that the anti-TIGIT monoantigen JS006 injection was approved for clinical trials of the drug.
preclinical results show that JS006 can specificly block TIGIT-PVR inhibition path, stimulate the activity of lethal immune cells, and secrete tumor killer factors.
-
J Neuro-Oncol: Focused ultrasound promises to treat the deadliest brain tumor
Time of Update: 2020-07-19
, June 29, 2020 /PRNewswire bioON, BioValley, an innovative application of focused ultrasound, pioneered by the University of Virginia School of Medicine, has shown promise to fight malignant glioma
-
Nature Cancer: Chinese Academy of Sciences, nutrition institute Yu Huiyong and other discover the new mechanism to regulate liver cancer metabolism reprogramming
Time of Update: 2020-07-18
on July 6, 2020, Yin Huiyong, Shanghai Institute of nutrition and health, Chinese Academy of Sciences, published online the latest research results entitled: aldolase B suppresses heparocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
-
Mol. Pharmaceutics: Canadian scientists develop new method to deliver cancer drugs accurately to tumors
Time of Update: 2020-07-14
Today, colorectal cancer a common type of cancer, with the highest incidence and fatality rates in the world, with nearly 2 million new cases and nearly 900,000 deaths in 2018 alone In China, the
-
Keytruda combination therapy for gastric cancer Murshadon reaches clinical trial partnership
Time of Update: 2020-06-17
Under the terms of the agreement, Dinghang Pharma will conduct a one-arm open label Phase 2 clinical study aimed at evaluating the effectiveness and safety of the combination therapy for patients with
